Cell Cycle Experiments

Case: In vitro pharmacological efficacy evaluation of ADC drug DS-8201a targeting HER2.

 

图片19.png图片20.png

Fig. The effects of different concentrations of DS-8201a on the cell cycle of the target cell SK-BR-3.

GPT Advantages


  • Extensive library of target cells (300+ cancer cell lines and humanized cell lines) and certified BSL-2 level laboratories.

  • Free provision of comparator antibody therapy for common viral infections.

  • Proficiency in Flow Cytometry and molecular analysis platforms.

  • Availability of immune system humanized mice for verifying the Fc effect (ADCC, ADCP, etc.) on ADC drug antibodies, including models like NCG-IL15, NCG-IL2, and NCG-SGM3.

  • Vast project experience.

  • Compliance with regulatory requirements for new drug application submissions.

  • Strict laboratory data storage standards to ensure experiment traceability.